120 related articles for article (PubMed ID: 5108037)
1. Tolbutamide: another view.
Nahum LH
Conn Med; 1971 Apr; 35(4):272-3. PubMed ID: 5108037
[No Abstract] [Full Text] [Related]
2. Controlled clinical trials and the tolbutamide controversy.
Lavietes PH
Conn Med; 1971 Apr; 35(4):271-2. PubMed ID: 4927818
[No Abstract] [Full Text] [Related]
3. The oral hypoglycemic controversy. Stay as sweet as you are.
Gregory DR
Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193
[No Abstract] [Full Text] [Related]
4. The tolbutamide controversy.
Compr Ther; 1975 May; 1(1):19-20. PubMed ID: 1222531
[No Abstract] [Full Text] [Related]
5. Drug fears dismissed.
Nature; 1970 Nov; 228(5272):599. PubMed ID: 4920015
[No Abstract] [Full Text] [Related]
6. [Heart death and oral antidiabetics; the last judgement].
Touber JL
Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083
[No Abstract] [Full Text] [Related]
7. Status of problem of usage of tolbutamide. Preliminary statements.
Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
[No Abstract] [Full Text] [Related]
8. Medical guest editorial: The oral diabetic drug controversy.
Am Fam Physician; 1975 Dec; 12(6):73-4. PubMed ID: 1202930
[No Abstract] [Full Text] [Related]
9. [Oral antidiabetic drugs].
Z Allgemeinmed; 1975 Feb; 51(5):235. PubMed ID: 1130116
[No Abstract] [Full Text] [Related]
10. Oral diabetic drugs again held hazardous.
J Tenn Med Assoc; 1975 Apr; 68(4):343. PubMed ID: 1117724
[No Abstract] [Full Text] [Related]
11. Letter: The UGDP scandal and cover-up.
Moss JM
JAMA; 1975 May; 232(8):806-8. PubMed ID: 1173182
[No Abstract] [Full Text] [Related]
12. [Oral therapy in diabetes].
Kirkeby K
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1620-1. PubMed ID: 4588817
[No Abstract] [Full Text] [Related]
13. [Tolbutamide and coronary heart disease].
Paasikivi J
Duodecim; 1971; 87(21):1405-8. PubMed ID: 5114598
[No Abstract] [Full Text] [Related]
14. Editorial: Oral hypoglycemic drugs.
Scoville AB
J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
[No Abstract] [Full Text] [Related]
15. [Evaluation of oral hypoglycemic agents following the University Group of Diabetes Program].
Sasaki A
Nihon Rinsho; 1977 Feb; 35(2):317-23. PubMed ID: 558370
[No Abstract] [Full Text] [Related]
16. Tolbutamide: hazards of leaks.
Nature; 1970 Jul; 227(5255):224-5. PubMed ID: 4913637
[No Abstract] [Full Text] [Related]
17. Audit confirms conclusions of UGDP study on oral diabetes drugs.
FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34-6. PubMed ID: 720789
[No Abstract] [Full Text] [Related]
18. [Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials].
Folling I
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1604-6. PubMed ID: 4769481
[No Abstract] [Full Text] [Related]
19. [University Group Diabetes Program. The UGDP investigation remains clinically unacceptable].
Aarseth S
Tidsskr Nor Laegeforen; 1976 Aug; 96(22):1148. PubMed ID: 951693
[No Abstract] [Full Text] [Related]
20. Tolbutamide study raises blood pressures.
Nature; 1970 Dec; 228(5278):1251-2. PubMed ID: 5536884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
